TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
about
Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotencyRole of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver FibrosisMicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancerNovel hepatocellular carcinoma molecules with prognostic and therapeutic potentialsNon-coding RNAs as theranostics in human cancersThe role of microRNAs in human liver cancersThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateImplications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyMicroRNA and signal transduction pathways in tumor radiation responsePrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesAnalysis of circulating microRNAs in adrenocortical tumorsUnraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitroTGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryosMiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinomaMiR-525-3p enhances the migration and invasion of liver cancer cells by downregulating ZNF395.MicroRNAs: new insights into the pathogenesis of endodontic periapical disease.Staged miRNA re-regulation patterns during reprogramming.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC.MiR-181b sensitizes glioma cells to teniposide by targeting MDM2.Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1α) in adult liver and controls expression of frizzled-6.Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing.Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet.Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.The role of microRNAs in liver cancer progression.MicroRNA expression in human endometrial adenocarcinomaIdentification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Progress risk assessment of oral premalignant lesions with saliva miRNA analysisPrognostic role of microRNA-181a/b in hematological malignancies: a meta-analysisTransforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM.microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinomaFunctional analysis of microRNAs in human hepatocellular cancer stem cellsMolecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?
P2860
Q26752448-2C5D8877-ADEE-4ADD-9D9E-25DE9B7481E6Q26774309-7AEDC075-3223-4E53-8FF1-9BB8077F9AADQ26777313-4A27105D-59F2-41E2-AE9E-2BDC79D462B0Q26824909-5F22B5F0-EC48-47DF-93B7-75C3F3DFAEC2Q26851250-C8BF7EDA-431B-4DC3-A6F1-829842B8C3CBQ26861699-91552913-2783-411C-8CC7-3E8C943F83A7Q27003050-F4C9E8CF-6CDA-4E3A-BBCD-879ECF569C77Q27005850-AD11189D-BD3B-49CD-BF49-89E3A12805B8Q27027546-229338B3-1861-40FD-BA79-60FDDC7E0FB7Q28272678-D1055695-007A-4444-85B9-21EC24B4089FQ28303947-C4566EC3-28AA-4BBF-9F53-FBDCD0D148C8Q28389159-BA1184DF-55EE-4611-85AB-B234D7C18B53Q28481447-35343AF4-AA09-4DED-A7F9-2004510D2257Q28593016-118C7AC4-95DA-4176-87E7-008867DFE397Q28658442-3707496D-EBC9-42CF-9428-0AD6E376EAC5Q31152555-92FBC8DB-FE76-4182-AFF0-F232696C5AE6Q33640951-79DBB323-5B43-4926-96D9-A3B8A94F2660Q33742151-310CDDE3-1DBE-4468-AF1C-6490887AF707Q33862088-01DF39AF-7639-4788-B999-0A389EF8D1DBQ34016378-D7055794-94B1-4A51-95E9-AC1F2FDFBA79Q34110436-C13E5AF9-52E2-4417-8E09-F2AF0225182FQ34136136-D81E362D-3AC5-4111-B198-D76BF326994CQ34208986-4792CF14-E4E2-4BCA-9848-8C251F169989Q34213102-54DBE636-A70C-4D14-B8A7-260F82E9AB07Q34309876-0AD6BC23-2877-418F-B16A-515F21FBD9B3Q34327011-0276697A-D5E1-466B-80C8-A751EE9AA1E5Q34384312-1BFA261B-7A92-46FC-BAD9-ADDB30F8373FQ34450467-EFA97FFA-47DE-4536-95F1-F731719BD293Q34543731-36E16FB6-3DE3-4246-B444-4C8526F56DE0Q34558443-EBE84F28-CA81-463D-B078-BFC2FD167695Q34599349-2D996542-614D-4B5B-9CC9-FCEDFFD23E2AQ34599354-B8DE2165-C181-4B75-A4B9-74B5A40ABFD7Q34627491-87ABE6EB-DE62-4690-9955-0AAE0037EF42Q34637868-F37B8F5C-7F1D-46D0-B0B0-A6E6BA124970Q34716744-51F65209-9F1B-44E0-80E4-349E5FFFBC67Q34899647-9EE0CFDA-42CC-4E04-952D-5B204C9B01F2Q34940543-CEC76A57-547A-479C-AD71-5B5481D892BDQ35038304-85A49656-AB44-42B2-BE79-98EA2F09DB22Q35048239-600416A8-D9E1-4D2B-8EF5-7F38DF41D0E8Q35048768-2D5BC7C8-61F9-4001-87AC-827FCA3242C8
P2860
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
TGFbeta-mediated upregulation ...... inogenesis by targeting TIMP3.
@ast
TGFbeta-mediated upregulation ...... inogenesis by targeting TIMP3.
@en
type
label
TGFbeta-mediated upregulation ...... inogenesis by targeting TIMP3.
@ast
TGFbeta-mediated upregulation ...... inogenesis by targeting TIMP3.
@en
prefLabel
TGFbeta-mediated upregulation ...... inogenesis by targeting TIMP3.
@ast
TGFbeta-mediated upregulation ...... inogenesis by targeting TIMP3.
@en
P2093
P2860
P356
P1433
P1476
TGFbeta-mediated upregulation ...... cinogenesis by targeting TIMP3
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2009.468
P407
P50
P577
2009-12-21T00:00:00Z
P5875
P6179
1034279146